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Ubiquitin-activating enzyme was purified from the yeast Smd~arorrt_vces cererisirte by covalent affinity chromatography on ubiquitin-Sepharose 
followed by HPLC anion-exchange chromatography. Enzyme activity was monitored by the ubiquitin-dependent ATP: “PPi exchange assay. The 
purified enzyme has a specific activity of I.5 Nnroi “PPi incorporated into ATP*min-‘*mg-’ at 37’C and pH 7.0 under standard conditions for 
substrate concentrations as described by Ciechanovcr et al. (1982) J. Biol. Chem. 257. 2537-2542. The catalytic activity showed a maximum at 
p1-I 7.0. Its molecular weight both in non-denaturing and in SDS-gel electrophoresis was estimated to be 115 kDa. suggesting a monomeric form. 
The isoelectric point determined by gel electrofocusing was approximately 4.7. Two protein bands differing slightly in electrophoretic mobility could 
bc distinguished when SDS gels were loaded with very small amounts of purified El and immunoblottcd. the one with higher molecular weight 
being clearly predominant. The same two bands were also found in anti-El immunoblots of crude yeast lysates prepared under broad protease 
inhibition. 
Yeast: Ubiquitin-activating enzyme 
1. INTRODUCTION 
Almost all functions of ubiquitin are mediated by its 
covalent attachment to target proteins [2.3]. In the 
course of the conjugation to acceptors the initial reac- 
tion is the activation of ubiquitin by ubiquitin-activa- 
ting enzyme, E 1. During this reaction ubiquitin is first 
adenylated at its C terminus in the presence of ATP with 
the release of pyrophosphate. In a second step of the 
activation mechanism ubiquitin is bound by a thiol site 
on El to form a high-energy thiol ester with the libera- 
tion of AMP [ 1,4]. After this central event, the ubiquitin 
moeity can be transferred to thio! sites on several dif- 
ferent E2 proteins (ubiquitin carrier proteins or ubiqui- 
tin conjugating enzymes) by a transesterification reac- 
tion [5]. Some of these E2 proteins are capable of di- 
rectly conjugating ubiquitin to acceptor proteins, others 
require the action of ES (ubiquitin-protein ligase) [6]. 
The resulting ubiquitin-protein conjugate formed be- 
tween the C-terminus of ubiquitin and E-amino groups 
of lysine residues of the substrate protein is of isopep- 
tide nature. 
The importance of El is underscored by its nhsnlnte 
rlbhrevicttiutw El. ubiquitin activating enzyme; E2. ubiquitin carrier 
protein; PEI-TLC, polyethylcnciminc thinlayer chromatography; Ub. 
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requirement for cell viability [6.7] and its key-position 
in the ubiquitin-conjugating pathway. 
We report a purification table based on activity 
measurements by the ubiquitin-dependent ATP:PPi ex- 
change assay [1,8] and some characteristics of El from 
yeast. 
2. MATERIALS AND METHODS 
Auxiliary cnzymcs and biochcmicals were purchased from Bochrin- 
gcr Mannheim (Mannheim, Germany) and Sigma (Dcisenhofcn. Ger- 
many). Ubiquitin was obtained from Sigma (Dciscnhofcn, Germany). 
Ubiquitin-Sepharose was synthesized using activated CH-Sepharose 
4B (Pharmacia. Freiburg. Germany) according to the manufacturer’s 
instructions. The final concentration of immobilized ubiquitin was IO 
mglml gel. Polyethylcneiminc thin-layer chromatography (PEI-TLC) 
plates ‘Fl4401PEI 20x20 cm’ were from Schlcicher and Schucll (Das- 
sel, Germany). [“PISodium pyrophosphate was from New England 
Nuclear (Drcicich. Germany). 
For assaying El the ATP:“PP, exchange reaction described by 
Ciechanover et’al. [8] was used. All substrate concentrations were as 
described [I] except for the assay buffer which was 0.1 M HEPES- 
NaOH pH 7.0. Incubation times were chosen to measure only within 
ik :iiiCZi il;iigC of ihC piGgiC% C;lT;C. Up tG Zpi;iZXiXl;tC!y !S% ?O!O 
tivc radioactivity in A unit enzyme activity defined as 
amount catalyzing incorporation of ,umol of into ATP 
minute at under standard as above. The 
wcrc started the addition enzyme preparation and 
stopped spotting 3 aliquots (- cpm) onto plates. 
After in 1.2 potassium phosphate pH the 
plates dried and ATP spots identified under UV 
The ATP were excised 
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for fraction II were run in the presence and absence of ubiquitin, and 
enzyme activity was calculated by the difference. After the ubiquitin 
affinity chromatography step the reaction was completely dependent 
on the presence of ubiquitin. 
2.3. Pwparation of frucliotr II 
S. cererisiae strain Ml was grown for 24 h at 30°C in YEPD 
medium (1% yeast extract. 2% Bacto peptonc. 2% glucose) to station- 
ary phase. Performance of the ATP depletion and preparation of the 
clarified lysate was as described by Jentsch et al. [9], except that the 
lysate was made from a 33% (w/v) cell suspension in 50 mM Tris-HCI 
pH 7.5. Following an overnight dialysis against 20 vol I mM DTT in 
50 mM Tris-HCI pH 7.5 the preparation of fraction II was performed 
as described in [IO. I l] except hat the basis-buffer used in all steps was 
50 mM Tris-HCI pH 7.5. The protein content of Frx II was typically 
I l-l I.5 mg/ml. 
2.4. Uhicpi!in c~fj%~i~~ clrrornarograpl, and FPLC 
Covalent affinity purification on ublquitin-Sepharose was mainly as 
described [I 1.121. Binding of E I and E2 proceeded for I5 min at room 
temperature and was performed as a batch adsorption. The ratio of 
fraction II to (immobilized) ubiquitin was 13: I. For the clution proce 
dure the ubiquitin-Sepharose was poured into a column with a rcsult- 
ing volume of 25 ml. AMP/PP,-elution and a consecutive DTT-elution 
was performed essentially as described by Haas and Bright [l2]. also 
the concentration of the eluates by ultrafiltration and subsequent 
FPLC anion-exchange chromatography on a MonoQ HR 5/5 column. 
from which El is eluted by a linear salt gradient of O-500 mM KCI. 
2.5. Elecrrophoresis. isoelectric fucrrshg 
Polydcrylamide clectrophoresis in the prcscnce of SDS was carried 
out as described by King and Laemmli [13]. Non-denaturing gcl- 
electrophoresis using polyacrylamide gradient (8-25%) gels and isoe- 
lectric focusing using Phast-IEF-gels (46.5) were done with a Phar- 
macia PhastSystcm according to the company’s recommendations. 
Gels wcrc stained for protein with Coomassie brilliant blue R-2SO and 
destained by diffusion. Molecular mass standards for SDS-gel elec- 
trophorcsis were prestained (with apparent molecular mass in kDa). 
myosin H-chain (211). phosphorylase B (107), BSA (69). ovalbumin 
(46). carbonic anhydrase (29). P-lactoglobulin (18). lysozyme (14). 
A rabbit was immunized against SDS-denatured El (I41 and 
boosted after 3, 5 and 7 weeks. Antiserum was collected 2 weeks 
thereafter. lmmunoblotting was done after elcctrophorcsis of the 
respective samples as described [15]. 
2.7. Proleih delc’r.rrri~uUiur~ 
Protein concentrations wcrc determined by the method of Bradford 
[I61 using BSA as standard. 
3. RESULTS AND DISCUSSION 
The procedure for isolating factors of the ubiquitin- 
conjugating system by the preparation of fraction II 
from ATP-depleted cells to remove endogenous ubiqui- 
tin, followed by covalent affinity chromatography on 
ubiquitin-Sepharose was developed by Hershko and 
colleagues [ 1 ,I I]. This method has proved to be applica- 
ble to a great variety of eukaryotic organisms like rabbit 
reticulocytes [ 1 I] and liver [ 171, human erythrocytes [I], 
chicken muscle [ 181, wheat germ [ 191 and yeast [9]. The 
ubiquitin-activating enzyme El can be eluted in a rela- 
tively selective manner from the ubiquitin-Sepharose 
matrix by reversing its enzymatic reaction with the addi- 
tion of AMP and pyrophosphate. This AMP/PP, eluate 
still contains small contaminations of ubiquitin-conju- 
gating enzymes E2 [20,12] that were probably released 
from the column by reversal of the ubiquitin-transes- 
terification reaction from El to E2 during the elution of 
El [20]. To remove those residual E2 contaminants an 
HPLC anion-exchange chromatography described by 
Haas and Bright for the resolution of E2 enzymes [12] 
on a MonoQ column proved to be very effective. In 
contrast to the situation found in preparations of reticu- 
locytes where El co-elutes with one of the E2s from the 
MonoQ column [12], we did not observe this elution 
pattern in yeast. Hence, additional El (see below) could 
easily be separated from the DDT eluate of the ubiqui- 
tin affinity chromatography by this step. Polyacryla- 
mide electrophoresis of the purified El is shown in Fig. 
1. Table I shows the purification procedure where the 
ubiquitin-Sepharose column was first eluted with AMP 
+ PP, (2 mM of each) and successively with DTT (10 
mM). As can be seen, the AMP/PPi elution yielded only 
approximately 213 of the column-bound El. The re- 
mainder l/3 of the total bound El could be released by 
a consecutive DTT-eluate (with the disadvantage of in- 
cluding all E2-proteins whose thiolesters are also 
cleaved). However, this impure preparation can 
be purified further by FPLC anion-exchange chroma- 
tography to a specific activity almost as high as that 
obtained for the further purified AMP/PPi eluate (Table 
I). 
ab 
Fig. I. SDS-polyacrylamide gel elcctrophoresis of El. 6,~~ El (purified 
from the AMP/PP;-eluatc) were loaded on a IO-20% gradient gel. lane 
a; molecular mass marker proteins, lane b. 
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Purification of ubiquitin-activating enzyme from Snccltclronr_rces cercrisiue starting with 140 g yeast (wet weight). Values marked with an asterisk 
are related to the activity measured in fraction 11 (see text). 
Step Volume 
(ml) 
Protein-cont. Total protein Spcc. activity Total activity Purification* Yield* 
(m%ml) !mg) (mU/mg) (mUI (-fold) (6) 
Crude extract 
Fraction II 
Ub-Aff. chrom.: 
AMPIPP, eluate 
DTT eluate 
FPLC: 
of AMP/PPi 
eluate 
of DDT cluatc 
400 20 8000 
300 II 3300 0.67* 221 I* I 100 
IO 0.045 0.45 1380 621 2060 28. I 
10.5 0.037 0.37 930 344 I388 15.5 
I 0.23 0.23 I560 359 2328 16.2 
I 0.115 O.! I5 1520 175 2269 7.9 
From the MonoQ column El eluted as a single peak 
at 225 mM KCl. 
The purification described here yielded 378 mU El 
(0.25 mg) from 100 g wet weight yeast with approxi- 
mately 1.5 U/mg. 
Calculations of ‘purification’ and ‘yield’ are related 
to fraction II because the 44TP:PPi exchange assay is not 
applicable in the crude ertract due to endogenous ubi- 
quitin. Moreover, the validity of the assay in fraction II 
is hampered by the permanent removal of ubiquitin 
from the isotope-exchange reaction by conjugation to 
endogenous acceptor proteins of fraction II. Neverthe- 
less, such information has been given before [l] and is 
useful for comparison with other organisms or purifica- 
tion protocols. Values relating on the activity in fraction 
II are therefore included but marked with an asterisk to 
indicate that in Frx II the actually measured activity is 
always an inevitable underestimate of the true El-ac- 
tivity. 
While the El-yield of the AMPIPPi-eluate from yeast 
(28.1%) is comparable to that from erythrocytes (36.6%. 
[ 1 I). greater differences are seen in the specific activities. 
Yeast El isolated from the AMP/PPi eluate exhibits a 
specific activity five times higher than the same prepara- 
tion from human erythrocytes [ 11. When comparing the 
difference in specific activity in the AMP/PPi eluates one 
has to consider that we used 0.1 M HEPES-NaOH pH 
7.0 instead of 0.05 M Tris-HCl pH 7.5. But this dif- 
ference can only in part be attributed to the different 
buffer conditions used. because the specific activity of 
yeast El at pH 7.5 is only slightly lower (approx. 3%) 
than at pH 7.0, as can be seen in the pH-profile (Fig. 
2). In addition yeast El activity at pH 7.5 was identical 
in both 0.05 M HEPES- or 0.1 M Tris-buffer in our 
hands. Dependence of ATP:PPi exchange activity of 
purified El on the pH is shown in Fig. 2. Maximal 
7 
PH 
4.5 - 
4- 
3.5 - 
9 
PH 
3- I I I I I ‘I I I 
0 5 10 15 20 25 30 35 40 ’ 
distance from cathode (mm> 
Fig. 2. Effect of pH on the ATP:PP, exchange activity ofpurilicd El. 
Each assay was pcrformcd with I I5 ng El. The maximal activity 
observed was set as 100% relative enzyme activity. Buffers wcrc 0.1 
M Na-acetate pH 5.0; 0. I M MES-NaOH at 5.5-6.5: 0. I M HEPES- 
NaOH pH 7.0-7.5; 0.1 M Tris-HCI pH 8.0-9.0. II(C3666). 
Fig. 3. Isoelectric focusing of El. Estimated isoelectric point. 4.7, 
Isoelectric points of reference proteins arc: a. carbonic anhydrase I 
(6.6): b. carbonic anhydrasc II* (5.9);~. carbonicanhydrase II** (5.4): 
d.@lactoglobulin A (5.1); e. soybean trypsin inhibitor (4.6); f. glucose 
oxidasc (4.2); g, amylnglycosidase (3.6). *CA II (C6403). **CA 
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Fig. 4. Estimation of the molecular mass of purified El by non- 
denaturing gel electrophoresis. Estimated molecular mass. 15 kDa. 
The relative elcctrophoretic mobilities (Hr) of the protein-stained 
bands of El and reference proteins are compared. (molecular mass in 
kDa) a. thyroglobulin (669); I>. ferritin (440); c. catalase (232); d, 
lactate dehydrogenase (140): BSA (67). 
activity was observed at pH 7.0. To ensure that the 
pyrophosphate is not hydrolyzed during incubations at 
acid pH, a mock assay at pH 5 was done for 1 h without 
added E! . After PEI-TLC the TLC plate was autoradio- 
graphed and compared to identical runs with 3’PPi and 
A 
ng El 
208 42 
69r 
‘~Pi standards. There was no hydrolysis of pyrophos- 
phate detectable. The pH optimum at pH 7 seems to be 
of physiological significance as the cytosolic pH in yeast 
is reported to be neutral [21]. The isoelectric point of El 
was measured by isoelectric focusing in a polyacryla- 
mide gel. A p1 of 4.7 was determined by comparison of 
the protein-stained band with marker proteins (Fig. 3). 
The molecular mass of the native protein, determined 
by non-denaturing gel electrophoresis was estimated to 
be 115 kDa (Fig. 4). This result in conjunction with the 
molecular mass observed in SDS-gels (cf. Fig. 1) suggest 
El exists as a monomer. 
Antiserum against SDS-denatured enzyme was raised 
in a rabbit. This anti-El antiserum recognized both 
SDS-denatured and native enzyme in immunoblot ex- 
periments (not shown). In contrast to antiserum against 
wheat germ El [19] the anti-yeast El antiserum did not 
crossreact with El from mammalian sources (human 
and rabbit tested, see Fig. 5b, lane b and c). 
As shown in Fig. 5a, in immunoblotting experiments 
with the anti-El antiserum a faint second band with 
slightly lower molecular weight could be distinguished 
from the El band seen in Coomassie-stained gels with 
purified El (due to the better resolution when small 
amounts of protein are loaded in conjunction with the 
sensitive detection method). The observation of two or 
more closely related forms of E 1 that differ only slightly 
in molecular weight has also been reported for El from 
humans [22], mouse [23], rabbit [ 191 and oat [ 191. As this 
double band was also detected in crude extracts pre- 
pared under broad protease inhibition (antipain 50 pg/ 
ml? aprotinin 20 p&/ml, chymostatin 100 &ml, EDTA 
B 
ahcd 
15) I’ 
Fig. 5. Anti El-immunoblotting. Panel A: resolution of two separate bands from purified El. Small amounts of protein (ng El as indicated) were 
run in an 8% polyacrylamide gel in the presence of SDS and an immunoblot with anti-El antiserum was performed as described in section 2. Panel 
B: comparison of different El-sources. Electrophorcsis and immunoblotting was as dcscribcd in Panel A. Lane a, OSpg purified El; lane b, I pg 
AMP/PP, eluate from rabbit rcticulocytcs; lane c, I pg AMPIPP, eluate from human erythrocytes; lane d, 30 pg crude yeast preparation 
(set text). 
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1 mM, EGT’A 1 mM, leupeptin 20 ,@nl, pepstatin A 
20/@ml), (Fig. 5b, lane d), it is probably not an artefact 
due to proteolysis during the purification procedure. 
As there seems to be only one El-encoding gene in 
yeast and its deletion results in cell death [3,7], the two 
E 1 forms observed probably represent a covalent modi- 
fication of the same enzyme. While this work was under 
way McGrath et al. reported some evidence for the 
existence of a ubiquitin-E 1 adduct of isopeptide nature 
[7]. This could be a possible explanation for the observa- 
tion of the two closely related bands in the immunoblot- 
ting experiments. 
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